Janssen Pharmaceuticals, Inc., also known as JanssenUS, is a subsidiary of Johnson & Johnson, a multinational pharmaceutical company based in the United States. JanssenUS focuses on developing and manufacturing innovative pharmaceutical products to treat various diseases and medical conditions. The company has a rich history that dates back to 1953 when Dr.

Paul Janssen founded Janssen Pharmaceutica in Belgium. In 1961, Janssen Pharmaceutica established its first international subsidiary in the United States, later becoming Janssen Pharmaceuticals, Inc. JanssenUS has since become a leader in the pharmaceutical industry, with a commitment to improving patient healthcare worldwide.

JanssenUS has its headquarters in Beerse, Belgium. The company operates globally, with offices, research facilities, and manufacturing plants in various countries. It also has numerous subsidiaries, joint ventures, and partnerships worldwide.

Notable subsidiaries include Janssen Biotech, Inc., Janssen-Cilag Pharmaceutical, and Janssen Pharmaceutical K. K. JanssenUS offers a wide range of products and services in different therapeutic areas, including cardiovascular and metabolic diseases, immunology, infectious diseases, neuroscience, and oncology.

Some of its well-known products include Remicade, a treatment for autoimmune diseases, Janssen HIV medications, and Stelara, a medication for psoriasis. In terms of market position, JanssenUS is highly regarded as a leading pharmaceutical company. It competes with other major players in the industry, such as Pfizer, Novartis, and Roche.

JanssenUS has achieved significant global sales, contributing to the success of its parent company, Johnson & Johnson. Over the years, JanssenUS has made significant achievements and undergone strategic changes. The company has expanded its product portfolio through acquisitions, collaborations, and in-house research and development.

It has also invested in cutting-edge technologies and innovative therapies to address unmet medical needs. As of the current status, JanssenUS continues to focus on developing and delivering breakthrough treatments to improve patients' lives. The company remains at the forefront of medical advancements, collaborating with healthcare professionals, researchers, and organizations worldwide to find innovative solutions to healthcare challenges.

Unfortunately, it seems that no recent or specific updates regarding JanssenUS or its latest accomplishments are available at this time